• SENSEX 80,737.51
    -636.24 (--0.78%)
  • BANKNIFTY 55,599.95
    -303.45 (--0.54%)
  • Yes Bank
    20.77 16.02(%)
  • Vodafone Idea
    6.74 6.46(%)
  • Aptus Value Hou.
    305.00 267.75(%)
  • TCS
    3,399.40 3,060.25(%)
  • Larsen & Toubro
    3,617.00 2,967.65(%)
  • Eternal Ltd
    236.80 146.85(%)
  • Zinka Logistics
    451.35 548.00(%)
  • M & M
    3,065.15 3,276.30(%)
  • HDFC Bank
    1,920.00 1,452.85(%)
  • Garden Reach Sh.
    3,188.75 3,188.75(%)
  • Cochin Shipyard
    2,049.70 2,977.10(%)
  • Reliance Industr
    1,403.00 1,115.55(%)
  • Suzlon Energy
    67.95 45.13(%)
  • Kotak Mah. Bank
    2,033.40 1,602.20(%)
  • Brainbees Solut.
    393.00 734.25(%)
  • Infosys
    1,535.35 1,307.10(%)
  • ICICI Bank
    1,431.75 1,051.50(%)
  • Bharti Airtel
    1,831.75 1,224.50(%)
  • Reliance Power
    58.50 23.26(%)
  • Axis Bank
    1,175.00 934.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bliss GVS Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 79.0
  • ISIN : INE416D01022
133.16 -1 (-0.43%)
  • As on 03 Jun 2025 (EOD)

  • Today’s Low

    132.52

  • Today’s High

    136.88

  • Open

    133.50

  • Perv Close

    133.74

  • 52W Low

    92.15

  • 52W High

    185.50

Key Indicators

  • P/E(TTM)

    20.31

  • Mar.Cap (₹Cr.)

    1,403.11

  • Div & Yield %

    0.38

  • Book Value(₹)

    100.47

  • Debt-Equity Ratio

    -0.43

  • AGM Date

    03-Jun-2025

  • EPS

    6.55

  • P/E Ratio

    20.31

Financials Ratios

  • Debt-Equity Ratio

    0.11

  • Mar.Cap (₹Cr.)

    1,403.11

  • RONW (%)

    11.02

  • ROCE (%)

    14.84

Score Board

  • Equity (₹ in Cr.)

    10.54

  • BV (₹)

    100.50

  • Sales( ₹ in Cr.)

    667.20

  • NP (in Cr.)

    68.97

  • NP Var(%)

    -9.0

  • Div%

    50.0

  • CPS (₹)

    9.10

  • EPS (₹)

    6.50

  • Traded Value (₹ in Lakhs)

    1,401.42

  • 52 Week High

    185.50

  • 52 Week Low

    92.15

  • Price BSE

    133.0

  • Price NSE

    133.00

  • Market Capital( in Cr.)

    1,401.42

  • P/C Ratio

    14.60

  • P/E Ratio

    20.30

  • Price Vs.BV

    6.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 605.46 598.34 636.36 465.51 441.95 426.59
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 605.46 598.34 636.36 465.51 441.95 426.59
Other Income 33.50 50.77 35.37 17.68 37.00 35.81
Stock Adjustments 6.36 -21.24 8.90 8.85 -2.37 3.68
Total Income 645.32 627.87 680.63 492.04 476.58 466.08
EXPENDITURE :            
Raw Materials 305.83 293.66 352.84 262.15 234.36 228.83
Power and Fuel Cost 8.81 5.80 7.09 6.99 4.70 3.57
Employee Cost 82.59 72.54 65.06 58.61 44.02 33.85
Other Manufacturing Expenses 17.25 11.57 11.54 7.49 6.23 6.49
Selling and Administration Expenses 66.73 66.90 67.07 36.90 36.23 43.93
Miscellaneous Expenses 64.52 36.48 32.45 10.76 13.88 20.51
Employee Benefit Expenses 82.59 72.54 65.06 58.61 44.02 33.85
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 545.74 486.95 536.05 382.90 339.42 337.17
Operating Profit 99.59 140.93 144.57 109.14 137.16 128.91
Interest 5.81 10.06 4.32 4.19 6.62 3.15
Gross Profit 93.78 130.87 140.25 104.95 130.54 125.76
Depreciation 23.52 15.17 13.85 13.76 8.83 5.75
Profit Before Tax 70.26 115.70 126.40 91.19 121.71 120.01
Current Tax 26.34 34.42 31.92 21.52 31.81 45.44
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -6.72 -4.21 1.81 2.16 -2.44 0.14
Reported Net Profit 50.64 85.48 92.66 67.50 92.33 74.43
Extraordinary Items -25.47 0.26 2.09 -0.02 0.53 -1.47
Adjusted Net Profit 76.11 85.22 90.57 67.52 91.80 75.90
Adjustment below Net Profit -0.15 -0.67 0.30 0.52 -0.26 -0.17
P & L Balance brought forward 846.18 765.33 676.22 613.36 533.69 471.84
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 4.10 3.97 3.86 5.16 12.41 12.41
P & L Balance carried down 892.57 846.18 765.33 676.22 613.36 533.69
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 50.00 50.00 50.00 50.00 100.00
Dividend Per Share(Rs) 0.50 0.50 0.50 0.50 0.50 1.00
Earnings Per Share-Unit Curr 4.84 8.21 8.94 6.54 8.95 7.22
Earnings Per Share(Adj)-Unit Curr 4.84 8.21 8.94 6.54 8.95 7.22
Book Value 94.41 89.96 82.12 73.26 66.21 58.49
Book Value(Adj)-Unit Curr 94.41 89.96 82.12 73.26 66.21 58.49

Shareholding Pattern

  • Promoter Group

    35.29%

  • Public Share Holding

    64.71%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 37,187,174 35.29 37,187,174 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 37,187,174 35.29 37,187,174 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 13,887,912 13.18 13,887,912 42
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6,901,355 6.55 6,901,355 1
Mutual Funds / UTI 2,374 0.00 2,374 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 20,791,641 19.73 20,791,641 45
2] Non Institution
Bodies Corporate 7,532,767 7.15 7,488,327 208
Clearing Members 29,841 0.03 29,841 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,368,559 1.30 1,279,199 832
Foreign Non Institution Other 200 0.00 200 1
Hindu Undivided Families 1,234,589 1.17 1,234,589 867
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,813,680 9.31 9,813,680 6
Individuals holding nominal share capital up to Rs. 1 lakh 24,573,678 23.32 23,328,826 47,524
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2,609,357 2.48 2,609,357 3
Sub Total 47,391,457 44.98 46,012,805 49,465
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 105,370,272 100.00 103,991,620 49,517

Company Background

Bliss GVS Pharma LtdPharmaceuticals - Indian - Formulations

  • Bliss GVS Pharma Ltd
  • BSE Code : 79.0
  • ISIN : INE416D01022

  • Incorporation Year

    1984

  • Registered Office

    102 Hyde Park Sakivihar Road
    Andheri East, Mumbai,
    Maharashtra-400072

  • Telephone

    91-22-42160000

  • FAX

    91-22-28563930

  • Chairman

    Nandkumar Kashinath Chodankar

  • Managing Director

    Gagan Harsh Sharmma

  • Company Secretary

    Aditi Bhatt

  • Auditor

    Kalyaniwalla & Mistry LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Universal Capital Sec. Pvt Ltd
    21 Shakil Niwas,
    Mahakali Caves Road,Andheri (E)
    Mumbai - Mumbai - 400 093

Bliss GVS Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bliss GVS Pharma 133.00 638.96 605.46 20.31 11.19
Abbott India 31,061.15 6,097.18 5,848.91 46.66 44.71
Astrazeneca Phar 9,334.25 1,330.33 1,295.53 201.60 33.26
P & G Health Ltd 5,742.35 1,166.89 1,151.26 37.95 39.76
Glaxosmi. Pharma 3,223.65 3,530.73 3,407.25 59.42 44.44
Cipla 1,472.80 17,645.00 16,574.34 23.06 20.10
Novartis India 1,006.90 396.75 335.07 24.64 15.57
Amrutanjan Healt 730.95 437.58 421.23 41.58 20.84
Fermenta Biotec. 324.00 315.24 307.09 14.11 4.10
Guj. Themis Bio. 306.40 174.19 169.82 68.39 44.82
Ambalal Sarabhai 37.52 11.70 3.81 34.74 1.92